Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances.
Pubblicato: 2026-04-01
Heart failure clinics
MediLens Indicizzato: 2026-04-02
The diagnosis and treatment of cardiac amyloidosis have significantly progressed over the last decade, focusing on the pathogenesis of the disease. Noninvasive imaging has enhanced the diagnosis of ATTR cardiomyopathy, while novel treatments, including protein stabilizers and gene editing, have e...
Leggi su PubMed